Table 4.

Pathological classification of acute cholecystitis in the H and MD treatment groups (according to definitions of the Tokyo Guidelines)

	H-mediated VLC	MD-mediated VLC	P*
	(21 patients)	(21 patients)
Edematous cholecystitis: first stage	6 (28.5%)	5 (23.8%)	ns*
Necrotizing cholecystitis: second stage	13 (61.9%)	15 (71.4%)	ns*
Suppurative cholecystitis: third stage	2 (9.5%)	1 (4.7%)	ns*

*chi-square test.